NEO100 and High-Grade Meningioma
Trial details
- Registry ID
- NCT05023018
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| NEO100 and High-Grade MeningiomaNCT05023018 | Neonc Technologies, Inc. | Phase 2 | Recruiting | 2026-12-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |